Rallybio (RLYB)
(Delayed Data from NSDQ)
$1.59 USD
-0.18 (-10.17%)
Updated May 20, 2024 04:00 PM ET
After-Market: $1.59 0.00 (0.00%) 6:26 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.43 |
EPS Last Quarter | -0.47 |
Last EPS Surprise | 6.00% |
ABR | 1.40 |
Earnings ESP
|
-6.98% |
---|---|
Current Year | -1.47 |
Next Year | -1.27 |
EPS (TTM) | -1.88 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.43 | -0.37 | -1.47 | -1.27 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | -0.46 | NA | -1.57 | -1.22 |
High Estimate | -0.40 | -0.37 | -1.06 | -0.81 |
Low Estimate | -0.46 | -0.37 | -1.77 | -1.77 |
Year ago EPS | -0.46 | -0.45 | -1.84 | -1.47 |
Year over Year Growth Est. | 6.52% | 17.78% | 20.11% | 13.61% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 1 |
Up Last 30 Days | 0 | 0 | 2 | 1 |
Up Last 60 Days | 0 | 1 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 0 | 1 |
Down Last 60 Days | 2 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.43 | -0.37 | -1.47 | -1.27 |
7 Days Ago | -0.43 | -0.37 | -1.58 | -1.37 |
30 Days Ago | -0.38 | -0.36 | -1.52 | -1.34 |
60 Days Ago | -0.39 | -0.38 | -1.60 | -1.49 |
90 Days Ago | -0.40 | -0.38 | -1.60 | -1.69 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.46 | -0.37 | -1.67 | -1.50 |
Zacks Consensus Estimate | -0.43 | -0.37 | -1.47 | -1.27 |
Earnings ESP | -6.98% | 0.00% | -13.86% | -18.02% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.47 | -0.50 | -0.45 | -0.46 | NA |
Estimate | -0.50 | -0.44 | -0.51 | -0.48 | NA |
Difference | 0.03 | -0.06 | 0.06 | 0.02 | 0.01 |
Surprise | 6.00% | -13.64% | 11.76% | 4.17% | 2.07% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more